We confirm previously reported FH mutations in nine of the 18 re-sequenced HLRCC probands (Smit et al. 2011) and report FH mutations in only two UL cases and also in one UL-free control. The gene discussed is FH; the disease is hereditary leiomyomatosis and renal cell cancer.